These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21254213)

  • 1. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of PARACEST agents with relaxation correction.
    Jones CK; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2010 May; 63(5):1184-92. PubMed ID: 20432289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems.
    Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.
    Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R
    Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.
    Winter PM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):389-98. PubMed ID: 22422650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
    McVicar N; Li AX; Meakin SO; Bartha R
    NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe).
    Li AX; Wojciechowski F; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2008 Feb; 59(2):374-81. PubMed ID: 18228602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-resonance low B1 pulses for imaging of the effects of PARACEST agents.
    Vinogradov E; Zhang S; Lubag A; Balschi JA; Sherry AD; Lenkinski RE
    J Magn Reson; 2005 Sep; 176(1):54-63. PubMed ID: 15979362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous in vivo pH and temperature mapping using a PARACEST-MRI contrast agent.
    McVicar N; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2013 Oct; 70(4):1016-25. PubMed ID: 23165779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of Peripheral Carboxylates to Decrease the Charge on Tm(3+) DOTAM-Alkyl Complexes: Implications for Detection Sensitivity and in Vivo Toxicity of PARACEST MRI Contrast Agents.
    Suchý M; Milne M; Elmehriki AA; McVicar N; Li AX; Bartha R; Hudson RH
    J Med Chem; 2015 Aug; 58(16):6516-32. PubMed ID: 26214576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI detection of paramagnetic chemical exchange effects in mice kidneys in vivo.
    Vinogradov E; He H; Lubag A; Balschi JA; Sherry AD; Lenkinski RE
    Magn Reson Med; 2007 Oct; 58(4):650-5. PubMed ID: 17899603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agents.
    Soesbe TC; Togao O; Takahashi M; Sherry AD
    Magn Reson Med; 2012 Sep; 68(3):816-21. PubMed ID: 22213371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of paraCEST agents using frequency labeled exchange transfer MRI.
    Lin CY; Yadav NN; Ratnakar J; Sherry AD; van Zijl PC
    Magn Reson Med; 2014 Jan; 71(1):286-93. PubMed ID: 23468384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI.
    Woessner DE; Zhang S; Merritt ME; Sherry AD
    Magn Reson Med; 2005 Apr; 53(4):790-9. PubMed ID: 15799055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.